Everest Medicines doses first participant in trial of EVM14 cancer vaccine
The Phase I dose-escalation study includes two cohorts: EVM14 as monotherapy and in combination with a PD-1 monoclonal antibody.
Trilink Thematic mRNA WP
NHS England to expand trial access for head and neck cancer vaccine
Moderna’s mRNA flu shot outperforms current standard at Phase III
FDA clears CureVac’s IND application for Phase I lung cancer trial
Everest Medicines begins dosing in mRNA cancer vaccine trial
SK bioscience gains approval in Australia to begin trials of mRNA-based vaccine
Moderna and MSD begin trial of mRNA-4157 and Keytruda combination for lung cancer
Moderna’s norovirus vaccine enters Phase III trials in the UK
